You are here
December 12, 2023
Nanoplastics may help set the stage for Parkinson鈥檚 risk
At a Glance
- Scientists found that tiny plastic particles can enter nerve cells, impair breakdown of structures linked to Parkinson鈥檚 disease, and harm certain brain regions in mice.
- The findings point to molecular links between plastics and Parkinson鈥檚 disease mechanisms that can be further explored through additional research.
Parkinson鈥檚 disease and related dementias have been聽on the rise worldwide. These disorders are marked by an abnormal buildup of the protein alpha-synuclein in the brain. The factors leading to this buildup of alpha-synuclein are unknown. Research points to a potential role for environmental factors.
Small bits of plastic are widely found throughout the environment, including food and water supplies. Microplastics are plastic聽particles smaller than 5 mm in diameter鈥攖inier than a sesame seed; nanoplastics are less than 1 渭m, too small to be seen by the human eye. At least one previous study found that particles of polystyrene and other plastics can be detected in the blood of most healthy adults.聽Single-use polystyrene products鈥攍ike plastic cups, utensils, and foam packing鈥攁re widespread environmental waste.聽But despite their ubiquity, the potential health consequences of these plastics are only beginning to be studied and understood.
Previous studies found evidence that alpha-synuclein鈥檚 activities can be affected by polystyrene and other particles. An international research team led by Dr. Andrew B. West of Duke University decided to take a closer look at the effects that nanoplastics might have on nerve cells and the brain.聽The scientists explored interactions between alpha-synuclein and polystyrene nanoplastics both in lab dishes and in mice. Results were reported on November 17, 2023, in Science Advances.
The researchers first showed that human alpha-synuclein binds readily to polystyrene nanoplastics in a test tube. This binding led to the formation of abnormal alpha-synuclein structures called fibrils, a hallmark of Parkinson鈥檚 disease and related dementias.
The scientists next examined how alpha-synuclein fibrils and nanoplastics behave with cultured brain cells, or neurons. They found that both the fibrils and the plastics can enter neurons via endocytosis, in which the cell鈥檚 outer membrane engulfs targeted items. Once inside, both the fibrils and the plastics entered the cell鈥檚 lysosomes, membrane-bound organelles that serve as cellular garbage disposals. The researchers found that nanoplastics disrupted lysosome activities, slowing the breakdown of harmful clumps of alpha-synuclein.
The team next looked at how polystyrene nanoplastics and alpha-synuclein interact in the mouse brain. They found that the nanoplastics and alpha-synuclein fibrils also interacted there, which increased the spread of abnormalities across interconnected brain regions. Neurons in the brain鈥檚 substantia nigra region were especially affected. This brain region helps to control movement and is damaged in Parkinson鈥檚 disease and related dementias.
Taken together, these findings point to previously unrecognized interactions that could contribute to Parkinson鈥檚 disease risk and progression. Further research is needed to study how these interactions affect disease development and whether other types of plastics have similar effects.
鈥淣umerous lines of data suggest environmental factors might play a prominent role in Parkinson鈥檚 disease, but such factors have for the most part not been identified,鈥 West explains. 鈥淥ur study suggests that the emergence of micro and nanoplastics in the environment might represent a new toxin challenge with respect to Parkinson鈥檚 disease risk and progression.鈥
鈥攂y Vicki Contie
Related Links
- PET Scans of Heart May Aid Early Detection of Lewy Body Diseases
- Study Links Synthetic Chemicals to Liver Damage
- Test Distinguishes Parkinson鈥檚 Disease from Related Condition
- Tracking the Spread of Parkinson鈥檚 Proteins from Gut to Brain
References: Liu Z, Sokratian A, Duda AM, Xu E, Stanhope C, Fu A, Strader S, Li H, Yuan Y, Bobay BG, Sipe J, Bai K, Lundgaard I,聽Liu N, Hernandez B, Bowes Rickman C, Miller SE, West AB. Sci Adv. 2023 Nov 15;9(46):eadi8716. doi: 10.1126/sciadv.adi8716. Epub 2023 Nov 17. PMID:聽37976362.
Funding: NIH鈥檚 最新麻豆视频 Institute of Neurological Disorders and Stroke (NINDS), 最新麻豆视频 Eye Institute (NEI), 最新麻豆视频 Institute on Aging (NIA), 最新麻豆视频 Institute of General Medical Sciences (NIGMS), and Eunice Kennedy Shriver 最新麻豆视频 Institute of Child Health and Human Development (NICHD); Michael J. Fox Foundation for Parkinson鈥檚 Research; Aligning Science Across Parkinson鈥檚 initiative; 最新麻豆视频 Science Foundation; Research to Prevent Blindness; and Olle Engkvist Foundation.